SGLT2 inhibitors for treating diabetes in people with chronic kidney disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"SGLT2 inhibitors for Treating Diabetes in People With Chronic Kidney Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440341/all/Human_stem_cells_for_decompensated_cirrhosis_in_adults_New. Accessed 19 April 2024.
SGLT2 inhibitors for treating diabetes in people with chronic kidney disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440341/all/Human_stem_cells_for_decompensated_cirrhosis_in_adults_New. Accessed April 19, 2024.
SGLT2 inhibitors for treating diabetes in people with chronic kidney disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/440341/all/Human_stem_cells_for_decompensated_cirrhosis_in_adults_New
SGLT2 inhibitors for Treating Diabetes in People With Chronic Kidney Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440341/all/Human_stem_cells_for_decompensated_cirrhosis_in_adults_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - SGLT2 inhibitors for treating diabetes in people with chronic kidney disease
ID - 440341
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440341/all/Human_stem_cells_for_decompensated_cirrhosis_in_adults_New
DB - Evidence Central
DP - Unbound Medicine
ER -